200 related articles for article (PubMed ID: 26322980)
1. Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease.
de Chaisemartin L; Meatchi T; Malamut G; Fernani-Oukil F; Hosking F; Rault D; Bellery F; Cellier C; Dragon-Durey MA
PLoS One; 2015; 10(8):e0136745. PubMed ID: 26322980
[TBL] [Abstract][Full Text] [Related]
2. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.
Rashtak S; Ettore MW; Homburger HA; Murray JA
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):426-32; quiz 370. PubMed ID: 18304884
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.
Ankelo M; Kleimola V; Simell S; Simell O; Knip M; Jokisalo E; Tarkia M; Westerlund A; He Q; Viander M; Ilonen J; Hinkkanen AE
Clin Exp Immunol; 2007 Nov; 150(2):285-93. PubMed ID: 17803713
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I
Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
[TBL] [Abstract][Full Text] [Related]
5. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.
Niveloni S; Sugai E; Cabanne A; Vazquez H; Argonz J; Smecuol E; Moreno ML; Nachman F; Mazure R; Kogan Z; Gomez JC; Mauriño E; Bai JC
Clin Chem; 2007 Dec; 53(12):2186-92. PubMed ID: 17901114
[TBL] [Abstract][Full Text] [Related]
7. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Agardh D
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
[TBL] [Abstract][Full Text] [Related]
9. Celiac disease serology in dermatitis herpetiformis. Which is the best option for detecting gluten sensitivity?
Sugai E; Smecuol E; Niveloni S; Vázquez H; Label M; Mazure R; Czech A; Kogan Z; Mauriño E; Bai JC
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):197-201. PubMed ID: 17225447
[TBL] [Abstract][Full Text] [Related]
10. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.
Aleanzi M; Demonte AM; Esper C; Garcilazo S; Waggener M
Clin Chem; 2001 Nov; 47(11):2023-8. PubMed ID: 11673371
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides.
Prince HE
Clin Vaccine Immunol; 2006 Jan; 13(1):150-1. PubMed ID: 16426013
[TBL] [Abstract][Full Text] [Related]
12. [Predictive value of serological tests in the diagnosis of celiac disease].
Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
[TBL] [Abstract][Full Text] [Related]
13. Tissue transglutaminase antibody determination in celiac disease. Analysis of diagnostic specificity of anti-human IgA-type assays.
Földes-Papp Z; Demel U; Berry D; Domej W; Fuchs D; Tilz GP
J Immunoassay Immunochem; 2002; 23(2):211-27. PubMed ID: 12033644
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up.
Volta U; Granito A; Fiorini E; Parisi C; Piscaglia M; Pappas G; Muratori P; Bianchi FB
Dig Dis Sci; 2008 Jun; 53(6):1582-8. PubMed ID: 17985240
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease.
Sugai E; Vázquez H; Nachman F; Moreno ML; Mazure R; Smecuol E; Niveloni S; Cabanne A; Kogan Z; Gómez JC; Mauriño E; Bai JC
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1112-7. PubMed ID: 16860613
[TBL] [Abstract][Full Text] [Related]
16. Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis?
Kumar V; Jarzabek-Chorzelska M; Sulej J; Karnewska K; Farrell T; Jablonska S
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1295-300. PubMed ID: 12414763
[TBL] [Abstract][Full Text] [Related]
17. Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production.
Picarelli A; Sabbatella L; Di TM; Di CT; Vetrano S; Anania MC
Am J Gastroenterol; 2002 Jan; 97(1):95-8. PubMed ID: 11808976
[TBL] [Abstract][Full Text] [Related]
18. Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease.
Weiss B; Bujanover Y; Avidan B; Fradkin A; Weintraub I; Shainberg B
Isr Med Assoc J; 2004 Jan; 6(1):9-12. PubMed ID: 14740501
[TBL] [Abstract][Full Text] [Related]
19. Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA.
Marietta EV; Rashtak S; Murray JA
World J Gastroenterol; 2009 Feb; 15(7):845-8. PubMed ID: 19230045
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of coeliac disease serological markers in Down syndrome patients.
Rumbo M; Chirdo FG; Ben R; Saldungaray I; Villalobos R
Dig Liver Dis; 2002 Feb; 34(2):116-21. PubMed ID: 11926554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
